Zhengming Yan Selected Research

Zhengming Yan Research Topics

12	Neoplasms (Cancer) 08/2022 - 04/2008
3	Breast Neoplasms (Breast Cancer) 08/2022 - 09/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 06/2017
1	Triple Negative Breast Neoplasms 03/2013
1	Tics (Tic) 03/2013
1	Lymphoma (Lymphomas) 01/2013
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2013
1	Neoplasm Metastasis (Metastasis) 09/2012
1	Disease Progression 01/2009
1	Retinoblastoma (Glioblastoma, Retinal) 04/2008

4	Docetaxel (Taxotere)FDA Link 03/2013 - 01/2009
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 06/2014 - 09/2012
3	nirogacestatIBA 06/2014 - 09/2012
2	palbociclibIBA 08/2022 - 01/2009
1	Hormones (Hormone)IBA 08/2022
1	Cyclin-Dependent Kinase 4IBA 08/2022
1	ErbB Receptors (EGF Receptor)IBA 08/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	fimepinostatIBA 01/2021
1	CUDC-907IBA 01/2021
1	Gemtuzumab (Mylotarg)FDA Link 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	Immunoglobulin G (IgG)IBA 06/2017
1	Chemokine ReceptorsIBA 06/2017
1	Sunitinib (Sutent)FDA Link 06/2014
1	SurvivinIBA 03/2013
1	AntigensIBA 01/2013
1	Indicators and Reagents (Reagents)IBA 01/2013
1	LuciferasesIBA 01/2013
1	Sirolimus (Rapamycin)FDA Link 01/2013
1	Tissue ExtractsIBA 01/2013
1	alovudineIBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 09/2012
1	Messenger RNA (mRNA)IBA 09/2012
1	ThymidineIBA 03/2012
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 11/2010
1	Cadherins (E-Cadherin)IBA 11/2010
1	Monoclonal AntibodiesIBA 11/2010
1	PF-03732010 monoclonal antibodyIBA 11/2010
1	PF 00477736IBA 07/2009
1	Capsules (Microcapsules)IBA 01/2009
1	Bevacizumab (Avastin)FDA Link 01/2009
1	Antineoplastic Agents (Antineoplastics)IBA 01/2009
1	AG-012986IBA 04/2008